Issuer and reporting period
Important identity mismatch: The supplied filing is Redwoods Acquisition Corp.’s Form 10-K for the fiscal year ended December 31, 2023, filed April 16, 2024. It is not a filing for Greenland Mines Ltd.
Redwoods is a SPAC with no operating business or operating revenue. It said it was seeking a business combination, with an intended focus on carbon-neutral and energy-storage industries, and would not pursue a target principally operating in China, Hong Kong, or Macau. The filing describes a proposed merger with ANEW Medical, Inc.
Financial results and position
| Metric | 2023 | 2022 |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expense | $1.225 million | $534,000 |
| Trust investment interest income | $3.364 million | $1.656 million |
| Net income | $1.346 million | $1.233 million |
| Net cash used in operating activities | $1.263 million | $493,000 |
Net income was driven by interest on trust assets, not operating activity. The company recorded $690,572 of income tax expense in 2023 (versus $322,025 in 2022); warrant fair-value changes were a $26,500 expense in 2023, compared with a $555,917 gain in 2022.
At December 31, 2023, cash was $172,535, trust investments were $19.256 million, total assets were $19.456 million, and working capital deficit was $2.114 million. Total liabilities were $8.242 million, including $1.540 million in sponsor promissory notes, $4.313 million in deferred underwriting fees, and a $1.024 million excise-tax liability. The trust balance was $117.806 million at year-end 2022; substantial redemptions during 2023 reduced it. Cash decreased by $168,427 during 2023.
Redemptions in 2023 included 6,103,350 shares for approximately $63.169 million in March and 3,636,456 shares for approximately $39.255 million in November. The company withdrew $519,232 of trust interest to pay taxes. It disclosed that approximately $153,089 of tax-restricted funds were inadvertently used for operating expenses in Q3 2023 and later replenished with sponsor loans.
Material developments and proposed transaction
- In May 2023, Redwoods agreed to acquire ANEW Medical for stock based on an implied ANEW equity value of $60 million. Certain ANEW holders may receive up to 5 million additional shares if specified post-merger share-price targets are met.
- The agreement’s termination date was extended from November 2023 to March 4, 2024, then to June 4, 2024 under an April 16, 2024 side letter.
- After the reporting date, on April 12, 2024, Redwoods stockholders approved the business combination and related proposals. Holders elected to redeem 1,739,776 shares; the company said it would continue accepting reversals of redemption requests until closing. The filing does not say the merger had closed.
- Redwoods’ charter allows monthly extensions of the business-combination period through December 4, 2024, subject to $35,000 monthly trust deposits. The filing also identifies June 4, 2024 as the relevant deadline in its going-concern discussion and as the amended transaction termination date; these deadlines should not be conflated.
Outlook, risks, and unusual items
- Going concern: Management and the auditor cited substantial doubt about Redwoods’ ability to continue as a going concern because of limited cash, ongoing costs, and uncertainty about completing a transaction before the applicable deadline. The financial statements contain no adjustments for a potential failure to continue.
- Funding and dilution: The company relied on sponsor financing, including $1.540 million of outstanding non-interest-bearing notes at year-end, convertible at the sponsor’s option into common shares at $10 per share upon a merger. Further financing may be needed. The proposed transaction also includes advisor compensation of 240,000 shares for Del Mar, plus $4.313 million of deferred underwriting fees and deferred legal fees.
- Controls: Disclosure controls were deemed ineffective due to material weaknesses involving trust-fund withdrawals and tax payments, income-tax accounting/classification, and fair-value measurement. Management described remediation steps, but the filing does not establish that the weaknesses were fully remediated.
- Other exposures: The company recorded a $1.024 million excise-tax liability related to stock redemptions. It also cited potential CFIUS review arising from the sponsor’s China-based control, market and financing uncertainty related to geopolitical conflicts, and possible reduced trust returns if trust securities were liquidated and held in cash to address investment-company concerns.
- Liquidation risk: If no business combination is completed within the permitted period, public shares are to be redeemed from the trust, subject to taxes, expenses, and creditor claims; warrants and rights would expire worthless. The filing notes that public holders might receive less than $10.10 per share.
Most important facts to verify
- Confirm the issuer identity: this document is Redwoods Acquisition Corp., not Greenland Mines Ltd.
- Confirm whether the ANEW merger closed, the final applicable transaction and SPAC deadlines, and the status of any further extensions.
- Verify final redemptions, trust cash available at closing, and any financing or working-capital arrangements.
- Review the final merger capitalization and dilution, including contingent shares, sponsor note conversion, advisor shares, warrants, and deferred fees.
- Check whether the disclosed control weaknesses were remediated and whether trust funds and tax liabilities are accurately accounted for.
- Assess the final excise-tax obligation and whether CFIUS review or trust-account investment restrictions affect closing or shareholder proceeds.